주식회사 큐로셀

{
  "address": "대전광역시 유성구",
  "ceo_name": "김건수",
  "certificate": [
    {
      "cert_number": "20170300145",
      "changes": "",
      "disclosure_date": "2017-03-30",
      "first_cert_date": "2017-03-30",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2017-03-30 ~ 2019-03-29"
    },
    {
      "cert_number": "20190300236",
      "changes": "",
      "disclosure_date": "2019-03-28",
      "first_cert_date": "2017-03-30",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2019-03-30 ~ 2021-03-29"
    },
    {
      "cert_number": "20210507010006",
      "changes": "",
      "disclosure_date": "2021-05-07",
      "first_cert_date": "2017-03-30",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2021-03-30 ~ 2024-03-29"
    },
    {
      "cert_number": "20240508010016",
      "changes": "",
      "disclosure_date": "2024-05-08",
      "first_cert_date": "2017-03-30",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2024-03-30 ~ 2027-03-29"
    }
  ],
  "company_name": "주식회사 큐로셀",
  "corp_no": "131111-*******",
  "financials": {
    "2022": {
      "capital_stock": 4703625000,
      "cost_of_sales": 0,
      "current_assets": 41397340000,
      "current_liabilities": 106647940000,
      "gross_profit": 0,
      "net_income": -38885125000,
      "net_income_bs": -38885125000,
      "non_current_assets": 46590393000,
      "non_current_liabilities": 28937680000,
      "non_operating_expenses": 18426031000,
      "non_operating_income": 965517000,
      "operating_profit": -21424611000,
      "revenue": 0,
      "sga_expenses": 21424611000,
      "total_assets": 87987733000,
      "total_equity": -47597887000,
      "total_liabilities": 135585620000
    },
    "2023": {
      "capital_stock": 6806368000,
      "cost_of_sales": 0,
      "current_assets": 42786879000,
      "current_liabilities": 3270412000,
      "gross_profit": 0,
      "net_income": -29663583000,
      "net_income_bs": -29574854000,
      "non_current_assets": 62182507000,
      "non_current_liabilities": 42599434000,
      "non_operating_expenses": 2961414000,
      "non_operating_income": 4427584000,
      "operating_profit": -31129753000,
      "revenue": 0,
      "sga_expenses": 31129753000,
      "total_assets": 104969386000,
      "total_equity": 59099540000,
      "total_liabilities": 45869846000
    },
    "2024": {
      "capital_stock": 7099647000,
      "cost_of_sales": 0,
      "current_assets": 12727055000,
      "current_liabilities": 38750160000,
      "gross_profit": 0,
      "net_income": -38235077000,
      "net_income_bs": -38235077000,
      "non_current_assets": 59273673000,
      "non_current_liabilities": 3815711000,
      "non_operating_expenses": 2641306000,
      "non_operating_income": 1025161000,
      "operating_profit": -36618932000,
      "revenue": 0,
      "sga_expenses": 36618932000,
      "total_assets": 72000728000,
      "total_equity": 29434857000,
      "total_liabilities": 42565871000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "3,000,000,000",
      "changes": "3,000,000,000",
      "date": "2020-07-15"
    },
    {
      "amount": "6,000,000,000",
      "changes": "6,000,000,000",
      "date": "2020-07-15"
    },
    {
      "amount": "1,937,500,000",
      "changes": "1,937,500,000",
      "date": "2020-06-30"
    },
    {
      "amount": "7,017,740,000",
      "changes": "7,017,740,000",
      "date": "2019-01-21"
    }
  ],
  "main_products": "세포치료제",
  "phone": "042-863-****",
  "years": [
    2024,
    2023,
    2022
  ]
}